Beauty Farm Medical and Health Industry Inc. Stock

Equities

2373

KYG0929L1041

Personal Services

Market Closed - Hong Kong S.E. 04:09:09 2024-04-25 am EDT 5-day change 1st Jan Change
15.46 HKD -1.53% Intraday chart for Beauty Farm Medical and Health Industry Inc. +8.26% +39.53%

Financials

Sales 2024 * 2.69B 372M 2.91B Sales 2025 * 3.23B 446M 3.49B Capitalization 3.37B 466M 3.65B
Net income 2024 * 288M 39.79M 311M Net income 2025 * 371M 51.25M 401M EV / Sales 2024 * 1.32 x
Net Debt 2024 * 180M 24.85M 195M Net cash position 2025 * 173M 23.96M 188M EV / Sales 2025 * 0.99 x
P/E ratio 2024 *
11.4 x
P/E ratio 2025 *
9.46 x
Employees 3,941
Yield 2024 *
3.63%
Yield 2025 *
4.61%
Free-Float 13.75%
More Fundamentals * Assessed data
Dynamic Chart
Beauty Farm Medical and Health More than Doubles 2023 Profit MT
Beauty Farm Medical and Health Industry Inc. Proposes Dividend Distribution for the Year Ended December 31, 2023, Payable on 25 September 2024 CI
Beauty Farm Medical and Health Industry Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beauty Farm Medical and Health Industry Forecasts 100% Rise in Fiscal 2023 Profit MT
Beauty Farm Medical and Health Industry Inc. Provides Group Earnings Guidance for the Year Ended December 31, 2023 CI
Beauty Farm Medical and Health's Unit Subscribes for 100 Million Yuan Structured Deposits; Shares Down 3% MT
Certain Ordinary Shares of Beauty Farm Medical and Health Industry Inc. are subject to a Lock-Up Agreement Ending on 16-JAN-2024. CI
Beauty Farm Medical Subscribes for Wealth Management Products from Shanghai Pudong Development Bank MT
Beauty Farm Medical and Health Unit Buys Beauty Company Group for 8 Million Yuan MT
Beauty Farm Medical and Health Industry Inc. entered into an acquisition agreement of Hangzhou Yangongfang Beauty Co., Ltd. and Hangzhou Yanyibei Beauty Co., Ltd. and Hangzhou Shangcheng District Yantai Beauty Store for approximately RMB 8 million. CI
Beauty Farm Medical and Health Industry Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain Ordinary Shares of Beauty Farm Medical and Health Industry Inc. are subject to a Lock-Up Agreement Ending on 16-JUL-2023. CI
Beauty Farm Medical Buys Chinese Franchisee; Shares Jump 6% MT
Beauty Farm Medical and Health Industry Inc. commences an Equity Plan Buyback for 23,666,106 shares, representing 10% of its issued share capital, under the authorization approved on June 19, 2023. CI
Beauty Farm Medical Plans Repurchase of 2.4 Million Shares MT
More news
1 day-1.53%
1 week+8.26%
1 month+10.59%
3 months+54.75%
6 months+54.60%
Current year+39.53%
More quotes
1 week
14.28
Extreme 14.28
15.80
1 month
13.80
Extreme 13.8
16.80
Current year
9.38
Extreme 9.38
16.80
1 year
9.38
Extreme 9.38
31.45
3 years
9.38
Extreme 9.38
32.90
5 years
9.38
Extreme 9.38
32.90
10 years
9.38
Extreme 9.38
32.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 22-02-09
Director of Finance/CFO 52 15-02-28
Corporate Secretary 40 22-03-23
Members of the board TitleAgeSince
Director/Board Member 57 22-02-09
Director/Board Member 55 22-12-14
Director/Board Member 52 13-11-30
More insiders
Date Price Change Volume
24-04-25 15.46 -1.53% 50,000
24-04-24 15.7 +5.09% 98,000
24-04-23 14.94 +1.63% 69,500
24-04-22 14.7 -0.14% 135,000
24-04-19 14.72 +1.94% 129,500

Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT

More quotes
Beauty Farm Medical and Health Industry Inc is a China-based company mainly engaged in beauty services. The Company's diversified services cover traditional beauty services, medical beauty services and sub-health assessment and intervention services. The medical beauty services include non-surgical medical beauty services, such as energy instrument services and injection services, and surgical medical beauty services. The Company operates its flagship brand Beauty Farm and three other brands, namely Bailishi, Yenyuan and Xiokeer.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
14.31 CNY
Average target price
17.08 CNY
Spread / Average Target
+19.37%
Consensus

Annual profits - Rate of surprise